504 related articles for article (PubMed ID: 15915152)
1. Can cell systems biology rescue drug discovery?
Butcher EC
Nat Rev Drug Discov; 2005 Jun; 4(6):461-7. PubMed ID: 15915152
[TBL] [Abstract][Full Text] [Related]
2. The impact of systems approaches on biological problems in drug discovery.
Hood L; Perlmutter RM
Nat Biotechnol; 2004 Oct; 22(10):1215-7. PubMed ID: 15470453
[No Abstract] [Full Text] [Related]
3. Systems biology in drug discovery.
Butcher EC; Berg EL; Kunkel EJ
Nat Biotechnol; 2004 Oct; 22(10):1253-9. PubMed ID: 15470465
[TBL] [Abstract][Full Text] [Related]
4. Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery.
Fischer HP
Biotechnol Annu Rev; 2005; 11():1-68. PubMed ID: 16216773
[TBL] [Abstract][Full Text] [Related]
5. Biology calls the targets: combining RNAi and disease biology.
van Es HH; Arts GJ
Drug Discov Today; 2005 Oct; 10(20):1385-91. PubMed ID: 16253877
[TBL] [Abstract][Full Text] [Related]
6. Initial compound selection for sequential screening.
Young SS; Lam RL; Welch WJ
Curr Opin Drug Discov Devel; 2002 May; 5(3):422-7. PubMed ID: 12058618
[TBL] [Abstract][Full Text] [Related]
7. A systems biology approach to drug discovery.
Zhu J; Zhang B; Schadt EE
Adv Genet; 2008; 60():603-35. PubMed ID: 18358334
[TBL] [Abstract][Full Text] [Related]
8. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
9. Seeing is believing--visualizing drug delivery in vitro and in vivo.
Swartz H
Adv Drug Deliv Rev; 2005 Jun; 57(8):1085-6. PubMed ID: 15935867
[TBL] [Abstract][Full Text] [Related]
10. Oral osmotically driven systems: 30 years of development and clinical use.
Malaterre V; Ogorka J; Loggia N; Gurny R
Eur J Pharm Biopharm; 2009 Nov; 73(3):311-23. PubMed ID: 19602438
[TBL] [Abstract][Full Text] [Related]
11. The impact of systems biology and biosimulation on drug discovery and development.
Michelson S
Mol Biosyst; 2006 Jun; 2(6-7):288-91. PubMed ID: 16880946
[TBL] [Abstract][Full Text] [Related]
12. Computational systems biology in drug discovery and development: methods and applications.
Materi W; Wishart DS
Drug Discov Today; 2007 Apr; 12(7-8):295-303. PubMed ID: 17395089
[TBL] [Abstract][Full Text] [Related]
13. Target selection and pharma industry productivity: what can we learn from technology S-curve theory?
Brown D
Curr Opin Drug Discov Devel; 2006 Jul; 9(4):414-8. PubMed ID: 16889225
[TBL] [Abstract][Full Text] [Related]
14. Structure-based design of molecular cancer therapeutics.
van Montfort RL; Workman P
Trends Biotechnol; 2009 May; 27(5):315-28. PubMed ID: 19339067
[TBL] [Abstract][Full Text] [Related]
15. Network systems biology for drug discovery.
Arrell DK; Terzic A
Clin Pharmacol Ther; 2010 Jul; 88(1):120-5. PubMed ID: 20520604
[TBL] [Abstract][Full Text] [Related]
16. Nuclear magnetic resonance in target profiling and compound file enhancement.
Sun C; Hajduk PJ
Curr Opin Drug Discov Devel; 2006 Jul; 9(4):463-70. PubMed ID: 16889229
[TBL] [Abstract][Full Text] [Related]
17. Systems cell biology based on high-content screening.
Giuliano KA; Johnston PA; Gough A; Taylor DL
Methods Enzymol; 2006; 414():601-19. PubMed ID: 17110213
[TBL] [Abstract][Full Text] [Related]
18. The need for precompetitive integrative bionetwork disease model building.
Friend SH
Clin Pharmacol Ther; 2010 May; 87(5):536-9. PubMed ID: 20407459
[TBL] [Abstract][Full Text] [Related]
19. Timely synthetic support for medicinal chemists.
Potoski J
Drug Discov Today; 2005 Jan; 10(2):115-20. PubMed ID: 15718160
[TBL] [Abstract][Full Text] [Related]
20. Progress in standards for reporting omics data.
Taylor CF
Curr Opin Drug Discov Devel; 2007 May; 10(3):254-63. PubMed ID: 17554851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
